Template & Instructions - American Peptide Society

advertisement
Understanding Biology Using Peptides
Sylvie E. Blondelle (Editor)
American Peptide Society, 2005
Sample Manuscript: Just Replace This Text With Yours
Lenore M. Margoliath1, Khaled A. Farid2, Third A. Author3 and
Firstname L. Lastname4
1Department
of Cell and Molecular Biology; 2Department of Biomedical Sciences; 3Graduate
School of Oceanography; 4Department of Fisheries, Animal and Veterinary Sciences,
University of Rhode Island, Kingston, RI 02881, USA
Introduction
This is just a sample showing how your manuscript will look after publishing in the
proceedings book. Please do not change any of the settings – font style and size,
page size, margins, etc. The simplest way to format your article is to apply the styles
defined in this sample manuscript and shown (usually) in the selectable window on
the top of your MSWord editing environment. This paragraph is for example in the
style ApsProcNormal. If you copy the styles from this sample manuscript to your
manuscript, you can apply them there. Or you can just replace the text of this sample
manuscript with your text and figures. Electronically generated graphics before
inserting into the template should be stored in TIFF format in actual size with the
resolution 600 dpi.
Now back to the sample manuscript… Vibrio anguillarum infections result in
huge economic losses in the aquaculture industry annually. Pleurocidin, an
antimicrobial peptide (AMP) isolated in 1997 from winter flounder, exhibited MICs
in the micromolar range against a wide variety of fish and human pathogens [1].
Studies have shown a correlation between antimicrobial activity and the charges,
hydrophobicities, and hydrophobic moments of amphipathic peptides that are
capable of adopting an -helical structure [2]. Although the C-terminal acid is the
naturally-occurring form, synthetic pleurocidin amide is more potent and has been
shown to protect coho salmon from vibriosis in vivo [3]. No additional increase in
potency was obtained by adding a lysine at the N-terminus of pleurocidin amide to
increase the positive charge on the peptide [3]. To characterize the structural
determinants required for antimicrobial activity and to discover minimal sequences
for genetic engineering, we synthesized pleurocidin amide and two new pleurocidin
analogs LM4-1 and LM4-2 (see Figure 1). The analogs were responsible for helix
formation in cecropin A [4]. AMPs were screened against E.coli, V. anguillarum,
and V.carchariae.
Cecropin A
LM4-1
Pleurocidin
LM4-2
H-WKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2
H-GWGSFKKAAHVGKHVGK-NH2
H-GWGSFFKKAAHVGKHVGKAALTHYL-OH
H-GWGSFFKKAAHVGKHVGKAAL-NH2
Fig. 1. Sequences of cecropin A, native pleurocidin and synthetic pleurocidin analogs
Results and Discussion
Synthetic peptides pleurocidin amide (25 residues), LM4-1 ([des-F5]Pleurocidin 1-18
amide) and LM4-2 (pleurocidin 1-21 amide) were synthesized using Boc chemistry
on MBHA (1.1 mmol/g, 1g) resins in a CS-Bio peptide synthesizer. The N-terminal
Boc-group was left on during removal of Dnp from His residues using thiophenol in
DMF. Following low-high HF deprotection and cleavage with thiocresol and cresol
Table 1. Antibacterial activity of peptides
Minimum Bactericidal Concentration (µM)a
CSMHB
CSMHB + 1.5% NaCl
Peptide
V. anguillarum
E.coli (ZK4)
V. anguillarum
V. carchariae
Pleurocidin amide
25
100
100
100
LM4-1
>100
>200
>200
>100
LM4-2
100
200
>200
>100
Tachyplesin (control)
25
50
50
25
aMBC
is the minimum peptide conc. where bacterial growth was not observed at 21h
scavengers, the crude peptides were extracted from the resin with 10% aqueous
HOAc; material excluded from a Sephadex® G-25 column was pooled and
lyophilized, then dissolved in water, and analyzed by C18 RP-HPLC (Vydac
218TP54) with a gradient of 5-85% CH3CN in aq. 0.1% TFA.
Antibacterial assays were performed by evaluating the ability of synthetic
peptides to inhibit bacterial growth in cell cultures (Table 1). Just to show how to
insert another type of Figure, stereo picture is shown in Figure 2. Synthetic
pleurocidin amide exhibited similar antibiotic activity to tachyplesin, with the
desired activity against marine pathogens V. anguillarum and V. carchariae.
Pleurocidin was not as potent against E. coli as it was against V. anguillarum. The
pleurocidin analogs were an order of magnitude less active than the parent peptide,
and this result indicated that the C-terminus of pleurocidin might play a role in
stabilizing the helix. LM4-2 was more active than LM4-1, possibly indicating that
Phe6 is required for optimal helix formation and activity.
Fig. 1. A representative structure of GIDY. The ribbon shows the peptide backbone.
Acknowledgments
The work was funded by an USDA-NRICGP grant to L. Martin.
References
1. Cole, A. M., Weis, P. and Diamond, G. J. Biol. Chem. 272, 12008-12013 (1997).
2. Tossi, A., Sandri, L. and Giangaspero, A. Biopolymers 55, 4-30 (2000).
3. Jia, X., et al. Appl. Environ. Microbiol. 66, 1928-1932 (2000).
4. Merrifield, R. B., Vizioli, L. D. and Boman, H. G. Biochem. 21, 5020-5031 (1982).
Instructions:
The manuscripts for the Symposium Proceedings volume must be submitted not later
then 4:00 pm, Wednesday, June 22, 2005. We will not accept a manuscript unless at
least one of the co-authors participated in the meeting and the manuscript was
presented in the meeting.
Acceptance of manuscripts for publication in the Proceedings of the 19 th American
Peptide Symposium is pending review by an Editorial Board. To maintain the quality of
the Proceedings Volume, manuscripts that are scientifically unsound and/or do not
comply with the requested format will be rejected. When necessary, a manuscript will
be returned only once to the author for editing with a firm deadline for completing the
requested minor revisions.
All manuscripts must be submitted in their final version (fully complying with the
template, instructions and length) and exclusively electronically (no exceptions),
preferably via the web page (manuscript submission). In addition, a hard copy and a file
on a CD-ROM must be turned in at the Registration Desk during the meeting before the
above-mentioned deadline. To achieve our goal of shipping the CDrom version of the
Proceedings volume before the end of 2005, deadlines will be strictly applied (no
exception).
IT IS ESSENTIAL TO FOLLOW EXACTLY THE INSTRUCTIONS ON MANUSCRIPT
PREPARATION BELOW.
 Open the accompanying manuscript template (an MSWord file).
 After you open the downloaded file, edit as needed. The best way to edit is to
write your manuscript in a separate file and then copy and paste your text into
the template. Copy title, authors, affiliations, text, and references separately –
this way you will retain the styles defined in the template and be able to view your
manuscript exactly as it will appear in the book. You may apply the styles defined
in the template by placing the cursor in the appropriate paragraph and clicking
the style needed (ApsProcTitle, ApsProcAuthors, ApsProcAffil, ApsProcText,
ApsProcRef).
 Do not change the size of the defined page.
 Do not change the margins.
 Do not change the font definition. (If you try to “squeeze in” a little more text by
changing the page size, margins, or font size, your manuscript will be returned to
you for editing – the net result being unnecessary delays or the omission of your
work altogether.)
 Use the same style for references as shown in the template.
 Electronically generated graphics should be stored in TIFF format in actual size
(as it would appear in the printed manuscript) before inserting into the template
with the resolution 600 dpi. For halftone or color images, the resolution must be
at least 300 dpi.
 If you have color illustrations you also need to submit a black and white
version on a separate page for publication in the Proceedings Book. Color
illustrations will appear only on the CDrom version of the Proceedings (your




manuscript will be returned to you for inserting a black and white illustration if
missing).
When you are satisfied with the manuscript, save it under the name of your
choice, e.g., “SmithAB.doc” in the format of MSWord (do not name your
manuscript “19APS.doc” -- Macintosh users select PC version). All text editors
have the option to save files in this format – just choose “Save As Type.”
Make sure the information requested on the “Submit Manuscript Form” button is
completely filled out.
If you are submitting more than one manuscript, you must fill out separate forms
for each.
Download the copyright transfer form, print it out, fill it out completely and bring it
to the symposium or mail it to: Dr. Sylvie E. Blondelle, Torrey Pines Institute for
Molecular Studies, 3550 General Atomics Court, San Diego CA 92121, USA -- or
fax to: ++(858) 455-3804
Any inquiries can be communicated to:
Sylvie Blondelle – sblondelle@tpims.org
Download